每年研究成果
每年研究成果
Description
Figure S3. ERK inhibition can downregulate EGFR expression. (A) AsPC-1 cells were treated with indicated concentrations of PD98059 for 24, 48, and 72â h. p-ERK and EGFR protein levels were determined. (B) AsPC-1 cells were transfected with scramble or ERK siRNA for 48â h to evaluate the protein expression of ERK and EGFR. Actin was loaded as an internal control. (TIF 440 kb)
| 可用日期 | 2019 |
|---|---|
| 發行者 | Figshare |
研究成果
- 1 文章
-
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. W., Chang, L. H., Tu, H. J., Chang, C. D., Lai, M. J., Chen, Y. Y., Liou, J. P., Teng, C. M. & Pan, S. L., 5月 29 2019, 於: Clinical Epigenetics. 11, 1, p. 85 85.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取26 引文 斯高帕斯（Scopus）